Patents by Inventor Julie Roge

Julie Roge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9528997
    Abstract: The invention concerns an in vitro method for determining if an individual is infected by a bacterium of the Propionibacterium genus comprising: (i) detecting antibodies directed against at least one protein of sequence SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8, in a biological sample of the individual, and (ii) deducing therefrom that the individual is infected by a bacterium of the Propionibacterium genus. The invention further concerns the kit for diagnosing of such an infection.
    Type: Grant
    Filed: November 14, 2012
    Date of Patent: December 27, 2016
    Assignee: Diaxonhit
    Inventors: Julie Rogé, Hélène Nuyttens, Karine Mignon Godefroy, Damien Thomas, Virginie Pinchot
  • Patent number: 9103828
    Abstract: The invention concerns a method to determine if an individual is infected by a bacterium selected from the group consisting Streptococcus, Enterococcus and Peptostreptococcus genera comprising: (i) detection of antibodies directed against at least one protein of sequence SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8, in a biological sample of the individual, and (ii) deducing therefrom that the individual is infected by a bacterium selected from the group consisting of Streptococcus, Enterococcus and Peptostreptococcus genera. The invention further concerns the kit for diagnosing of such an infection.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: August 11, 2015
    Assignee: Diaxonhit
    Inventors: Karine Yvonne Gabrielle Mignon Godefroy, Hélène Nuyttens, Julie Roge, Damien Yann Marie-Joseph Thomas
  • Patent number: 8785145
    Abstract: The invention concerns an in vitro method for determining if an individual is infected by a gram-negative bacterium preferably on prosthesis comprising: (i) detection of antibodies directed against a polypeptide of sequence SEQ ID NO: 2 and antibodies directed against a polypeptide of sequence SEQ ID NO: 4, in a biological sample of the individual, and (ii) deduction therefrom that the individual is infected by a gram-negative bacterium. The invention further concerns the kit for diagnosing of such an infection.
    Type: Grant
    Filed: August 10, 2012
    Date of Patent: July 22, 2014
    Assignee: Ingen Biosciences
    Inventors: Karine Yvonne Gabrielle Mignon Godefroy, Hélène Nuyttens, Julie Roge, Damien Yann Marie-Joseph Thomas
  • Publication number: 20130040320
    Abstract: The invention concerns an in vitro method for determining if an individual is infected by a gram-negative bacterium preferably on prosthesis comprising: (i) detection of antibodies directed against a polypeptide of sequence SEQ ID NO: 2 and antibodies directed against a polypeptide of sequence SEQ ID NO: 4, in a biological sample of the individual, and (ii) deduction therefrom that the individual is infected by a gram-negative bacterium. The invention further concerns the kit for diagnosing of such an infection.
    Type: Application
    Filed: August 10, 2012
    Publication date: February 14, 2013
    Applicant: INGEN BIOSCIENCES
    Inventors: Karine Yvonne Gabrielle Mignon Godefroy, Hélène Nuyttens, Julie Roge, Damien Yann Marie-Joseph Thomas
  • Publication number: 20130040321
    Abstract: The invention concerns a method to determine if an individual is infected by a bacterium selected from the group consisting Streptococcus, Enterococcus and Peptostreptococcus genera comprising: (i) detection of antibodies directed against at least one protein of sequence SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6 or SEQ ID NO: 8, in a biological sample of the individual, and (ii) deducing therefrom that the individual is infected by a bacterium selected from the group consisting of Streptococcus, Enterococcus and Peptostreptococcus genera. The invention further concerns the kit for diagnosing of such an infection.
    Type: Application
    Filed: August 10, 2012
    Publication date: February 14, 2013
    Applicant: INGEN BIOSCIENCES
    Inventors: Karine Yvonne Gabrielle Mignon Godefroy, Hélène Nuyttens, Julie Roge, Damien Yann Marie-Joseph Thomas
  • Patent number: 8101190
    Abstract: The present invention relates to a method for determining if an individual is infected by a staphylococcus bacterium, comprising: determining if antibodies directed against at least 2 proteins comprising a sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, and SEQ ID NO: 6, are present in a biological sample of the individual, and deducing therefrom that the individual is infected by a staphylococcus bacterium.
    Type: Grant
    Filed: March 3, 2009
    Date of Patent: January 24, 2012
    Assignee: Ingen Biosciences
    Inventors: Camille Cyncynatus, Julie Roge, Damien Thomas, Helene Nuyttens
  • Publication number: 20100227810
    Abstract: The present invention relates to a method for determining if an individual is infected by a staphylococcus bacterium, comprising: determining if antibodies directed against at least 2 proteins comprising a sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, and SEQ ID NO: 6, are present in a biological sample of the individual, and deducing therefrom that the individual is infected by a staphylococcus bacterium.
    Type: Application
    Filed: March 3, 2009
    Publication date: September 9, 2010
    Inventors: Camille Cyncynatus, Julie Roge, Damien Thomas, Helene Nuyttens